Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment

Clinical trial NCT00480896 · COMPLETED

Trial details

NCT number: NCT00480896
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dermatitis, Atopic

Start date: 2004-06-01
Primary completion: 2005-11-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.